Experimental osteonecrosis induced by a combination of low-dose lipopolysaccharide and high-dose methylprednisolone in rabbits

被引:39
作者
Wu, Xinghuo [1 ]
Yang, Shuhua [1 ]
Duan, Deyu [1 ]
Zhang, Yukun [1 ]
Wang, Jing [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, Wuhan 430022, Peoples R China
基金
中国国家自然科学基金;
关键词
Steroid-associated osteonecrosis; Experimental; Lipopolysaccharide; Methylprednisolone;
D O I
10.1016/j.jbspin.2007.11.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The pathogenetic mechanisms involved in steroid-induced osteonecrosis are poorly understood. Appropriate experimental models of the human disease are indispensable to the understanding of successful treatment modalities for osteonecrosis. Methods: In the present experiment we devised a novel rabbit model of steroid-induced osteonecrosis by use of two low-dose LPS and three high-dose MPS to investigate the development of osteonecrosis. Thirty eight rabbits were used and tissue assessments were performed on proximal third and distal condyles of femora and humeri obtained 6 weeks after the administration of LPS and MPS. MRI of these regions and intraosscous pressure of proximal femur were obtained at 0 and 6 weeks. Other assessments included serum plasminogen activator/inhibitor ratio, cholesterol level, LDL/HDL ratio, and triglyceride levels at various time points. Results: The study showed that with this osteonecrosis induction protocol there was low animal mortality (6.2%), high rate of osteonecrosis (90%), induction of thrombotic state, and hypercholesterol/lipidemia. Discussion: On the whole, this is a novel modified animal model of steroid associated osteonecrosis and it would be useful for elucidating the pathogenesis of steroid associated osteonecrosis and developing preventive and therapeutic strategies. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:573 / 578
页数:6
相关论文
共 50 条
  • [31] Effects of high-dose intravenous methylprednisolone in children with acute rheumatic carditis
    Akcoral, A
    Oran, B
    Tavli, V
    Unal, N
    Cevik, NT
    [J]. ACTA PAEDIATRICA JAPONICA, 1996, 38 (01): : 28 - 31
  • [33] High Dose Methylprednisolone versus Low Dose in Correction of Congenital Acyanotic Heart Disease
    El Derh, Maha Sadek
    Abdelaziz, Noha Mohamed
    Twab, Samar M. Abdel
    [J]. EGYPTIAN JOURNAL OF ANAESTHESIA, 2022, 38 (01): : 220 - 228
  • [34] High-Dose versus Low-Dose Corticosteroids in COVID-19 Patients: a Systematic Review and Meta-analysis
    Tan, Rachel Si Jing
    Ng, Ka Ting
    Xin, Chua Ee
    Atan, Rafidah
    Yunos, Norazim Mohd
    Hasan, M. Shahnaz
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (09) : 3576 - 3586
  • [35] Low- Versus High-Dose Methylprednisolone in Adult Patients With Coronavirus Disease 2019: Less Is More
    Joshi, Seema
    Smith, Zachary
    Soman, Sana
    Jain, Saniya
    Yako, Atheel
    Hojeij, Marwa
    Massoud, Louis
    Alsaadi, Ayman
    Williams, Jonathan
    Kenney, Rachel
    Miller, Joseph
    Alangaden, George
    Ramesh, Mayur
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (01):
  • [36] The effect of high-dose methylprednisolone on laser-induced retinal injury in primates: an electron microscopic study
    Kanji Takahashi
    Tim T. Lam
    Jun Fu
    Mark O. M. Tso
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 1997, 235 : 723 - 732
  • [37] Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia
    Salton, Francesco
    Confalonieri, Paola
    Meduri, G. Umberto
    Santus, Pierachille
    Harari, Sergio
    Scala, Raffaele
    Lanini, Simone
    Vertui, Valentina
    Oggionni, Tiberio
    Caminati, Antonella
    Patruno, Vincenzo
    Tamburrini, Mario
    Scartabellati, Alessandro
    Parati, Mara
    Villani, Massimiliano
    Radovanovic, Dejan
    Tomassetti, Sara
    Ravaglia, Claudia
    Poletti, Venerino
    Vianello, Andrea
    Gaccione, Anna Talia
    Guidelli, Luca
    Raccanelli, Rita
    Lucernoni, Paolo
    Lacedonia, Donato
    Barbaro, Maria Pia Foschino
    Centanni, Stefano
    Mondoni, Michele
    Davi, Matteo
    Fantin, Alberto
    Cao, Xueyuan
    Torelli, Lucio
    Zucchetto, Antonella
    Montico, Marcella
    Casarin, Annalisa
    Romagnoli, Micaela
    Gasparini, Stefano
    Bonifazi, Martina
    D'Agaro, Pierlanfranco
    Marcello, Alessandro
    Licastro, Danilo
    Ruaro, Barbara
    Volpe, Maria Concetta
    Umberger, Reba
    Confalonieri, Marco
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (10):
  • [38] Toxic liver injury after high-dose methylprednisolone in people with multiple sclerosis
    Adamec, Ivan
    Pavlovic, Ivan
    Pavicic, Tin
    Ruska, Berislav
    Habek, Mario
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 25 : 43 - 45
  • [39] Pericentral liver cell necrosis associated with the use of high-dose intravenous methylprednisolone
    Lee, Hannah M.
    Ditelberg, Jeremy S.
    Kaplan, Marshall M.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (06) : 1533 - 1534
  • [40] Effect of high-dose methylprednisolone administration on immune functions in multiple sclerosis patients
    Wandinger, KP
    Wessel, K
    Trillenberg, P
    Heindl, N
    Kirchner, H
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1998, 97 (06): : 359 - 365